All steps in vaccine production need to be robust, reproducible, and safe, as pathogens or pathogenic antigens are frequently involved. There are currently many products ranging from advanced ...
The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...
The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results